EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:759087 - etaracizumab
| ChEBI ID | CHEBI:759087 |
| ChEBI Name | etaracizumab |
| Stars | |
| Last Modified | 30 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antipsoriatic A drug used to treat psoriasis. antirheumatic drug A drug used to treat rheumatoid arthritis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| etaracizumab (CHEBI:759087) has role antineoplastic agent (CHEBI:35610) |
| etaracizumab (CHEBI:759087) has role antipsoriatic (CHEBI:50748) |
| etaracizumab (CHEBI:759087) has role antirheumatic drug (CHEBI:35842) |
| etaracizumab (CHEBI:759087) is a organic molecular entity (CHEBI:50860) |
| INN | Source |
|---|---|
| etaracizumab | WHO MedNet |
| Synonyms | Source |
|---|---|
| ETARATUZUMAB | ChEMBL |
| HLM60 | ChEMBL |
| MEDI-522 | ChEMBL |
| Vitaxin | ChEMBL |
| Brand Names | Source |
|---|---|
| Abegrin | ChEMBL |
| Abegrin vitaxin | ChEMBL |
| Citations |
|---|